NL-OMON56034撤回不适用
Post market clinical follow-up study for the Pamira ICD lead family. - BIO|MASTER.Pamira study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Standard indication for ICD therapy according to clinical guidelines.
- •Planned for de novo implantation of a BIOTRONIK ICD in combination with a
- •Pamira ICD lead.
- •Ability and willingness to use the CardioMessenger and acceptance of the
- •BIOTRONIK Home Monitoring® concept.
- •See CIP 8.3.1.
排除标准
- •Mechanical tricuspid valve prosthesis or a severe tricuspid valve disease.
- •Cardiac surgical post-implantation procedure planned within 12 months.
- •See CIP 8.3.2.
研究者
相似试验
已完成
不适用
A post market clinical follow-up study with the Optimys Stem, with initial RSA analysisHip ArthroplastyHip replacement10023213NL-OMON47653Stichting SCORE150
招募中
不适用
Post Market Clinical Follow-up Study for the Amvia/Solvia Pacemaker FamilyBradyardiaslow heart rate10007521NL-OMON56135BIOTRONIK SE and Co.KG30
已完成
不适用
A post market clinical follow-up study with the artificial hip joint CBH Stem, with initial RSA analysiship arthroplastyhip replacement10023213NL-OMON47657Xpert Orthopedie150
招募中
不适用
A post market clinical follow-up study with the aneXys ceramys inlay DEM16.7M16.1Other secondary coxarthrosisOther primary coxarthrosisDRKS00018809Mathys Orthopädie GmbH150
已完成
不适用
A post market clinical follow-up study with the aneXys acetabular cup and ceramys inlayM16.1M16.7Other primary coxarthrosisOther secondary coxarthrosisDRKS00021508Mathys AG Bettlach150